| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/12/1992 | CA2087017A1 Streptomyces vectors for production of heterologous proteins |
| 01/12/1992 | CA2046543A1 Efficacious vaccines against bordetella pertussis comprising a combination of individually purified pertussis antigens |
| 01/11/1992 | WO1992001055A1 O-glycosylated ifn-alpha |
| 01/11/1992 | CA2084514A1 O-glycosylated ifn-alpha |
| 01/10/1992 | WO1992000995A1 Cyclic cell adhesion modulation compounds |
| 01/10/1992 | CA2087021A1 Cyclic cell adhesion modulation compounds |
| 01/10/1992 | CA2044510A1 Method for site-directed mutagenesis |
| 01/09/1992 | WO1992000525A1 Assay for detecting and/or quantifying a mammalian antibody response to epstein-barr virus membrane antigen |
| 01/09/1992 | WO1992000521A1 Diagnostic and prognostic methods based on soluble derivatives of the beta amyloid protein precursor |
| 01/09/1992 | WO1992000387A1 Neurofibromatosis gene |
| 01/09/1992 | WO1992000382A1 Gdf-1 |
| 01/09/1992 | WO1992000379A1 New promoter region |
| 01/09/1992 | WO1992000376A1 Mast cell growth factor |
| 01/09/1992 | WO1992000330A1 Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof |
| 01/09/1992 | WO1992000329A1 Surface complexed lymphotoxin |
| 01/09/1992 | WO1992000327A1 HUMAN MACROPHAGE INFLAMMATORY PROTEIN 2$g(a) |
| 01/09/1992 | WO1992000326A1 HUMAN MACROPHAGE INFLAMMATORY PROTEIN 2$g(b) |
| 01/09/1992 | WO1992000325A1 Anticoagulant polypeptides |
| 01/09/1992 | WO1992000324A1 Novel protein capable of causing differential growth of cell and production thereof by genetic engineering technology |
| 01/09/1992 | WO1992000323A2 HUMAN CYTOMEGALOVIRUS (HCMV) ANTIGEN pp150 |
| 01/09/1992 | WO1992000322A1 Insulin analogues with organ preferential action |
| 01/09/1992 | WO1992000321A1 Novel, protracted insulin analogues |
| 01/09/1992 | WO1992000311A1 Probes for detecting mutant p53 |
| 01/09/1992 | WO1992000098A1 Methods of inducing immune response to aids virus |
| 01/09/1992 | WO1992000093A1 Transfer factor and methods of use |
| 01/09/1992 | WO1992000092A1 Ligand for cd28 receptor on b cells and methods |
| 01/09/1992 | WO1992000091A1 Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof |
| 01/09/1992 | WO1992000087A1 Process for obtaining pure peptide transfer factor, transfer factor thus obtained and uses thereof |
| 01/09/1992 | WO1992000084A1 Substantially pure placental derived endothelial cell growth factor and uses thereof |
| 01/09/1992 | WO1992000055A1 Compositions and methods for the prevention and diagnosis of lyme disease |
| 01/09/1992 | WO1992000014A1 Method for treating colostrum by hydroxyapatite adsorption chromatography, an active fraction of colostrum thereby obtained, and a cellular medium containing same |
| 01/09/1992 | CA2086610A1 Transfer factor and methods of use |
| 01/09/1992 | CA2086334A1 Neurofibromatosis gene |
| 01/09/1992 | CA2086091A1 Human macrophage inflammatory protein 2o |
| 01/09/1992 | CA2086088A1 Human macrophage inflammatory protein 2.beta. |
| 01/09/1992 | CA2084510A1 Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof |
| 01/09/1992 | CA2084413A1 Compositions and methods for the prevention and diagnosis of lyme disease |
| 01/09/1992 | CA2064555A1 Probes for detecting mutant p53 |
| 01/08/1992 | EP0465404A2 Peptdidylhydroxylglycine N-C lyase and DNA coding therefor |
| 01/08/1992 | EP0465204A2 Vaccine against Lyme disease and a challenge model for evaluating vaccine efficacy |
| 01/08/1992 | EP0465189A2 Recombinant DNA expression vectors and DNA compounds that encode deacetylcephalosporin C synthase activity |
| 01/08/1992 | EP0465104A1 Method for the immunological determination of the carboxyterminal propeptide of type I procollagen |
| 01/08/1992 | EP0465097A2 Peptides having atrial natriuretic factor activity |
| 01/08/1992 | EP0465081A1 Viral decoy vaccine |
| 01/08/1992 | EP0465024A1 Control of microsporogenesis using externally inducible promoter sequences |
| 01/08/1992 | EP0465009A1 Antimicrobial peptides and plant disease resistance based thereon |
| 01/08/1992 | EP0464867A1 Fusion proteins of interleukin-alpha with hirudin |
| 01/08/1992 | EP0464590A2 Inhibition of coloration of human serum albumin |
| 01/08/1992 | EP0464553A2 DNA clone encoding precursor of lectin-like substance from Periplaneta americana and cloning therefor |
| 01/08/1992 | EP0464549A1 Calcitonin analogues and use thereof |
| 01/08/1992 | EP0464533A1 Fusionproteins with parts of immunoglobulins, their production and use |
| 01/08/1992 | EP0464517A2 Amino acid derivatives with renin inhibiting activity |
| 01/08/1992 | EP0464300A2 Process for producing alpha-amylase inhibitor derived from wheat seed |
| 01/08/1992 | EP0464287A1 Non-A, non-B hepatitis virus genomic cDNA and antigen polypeptide |
| 01/08/1992 | EP0464184A1 Process for enzymatically treating substrates |
| 01/08/1992 | EP0464175A1 Extracellular form of the human fibroblast growth factor receptor |
| 01/08/1992 | EP0464147A1 Matrix metalloproteinase inhibitor peptides |
| 01/08/1992 | EP0464022A1 Insulinotropic hormone |
| 01/08/1992 | EP0462184A4 Method of treating viral infections using lfa-1 |
| 01/08/1992 | CN1057672A Immobilization of biomolecules by enhanced electrophoretic precipitation |
| 01/08/1992 | CN1057655A Ws7622a mono-or di-sulfate, process for preparation thereof and use thereof |
| 01/07/1992 | WO1992001041A1 A cDNA ENCODING THE RAT D1 DOPAMINE RECEPTOR LINKED TO ADENYLYL CYCLASE ACTIVATION AND EXPRESSION PRODUCT |
| 01/07/1992 | WO1992001001A1 Production of outer membrane (om) proteins in gram-positive bacteria and recovery of protective epitopes |
| 01/07/1992 | WO1992000750A1 Retroviral protease inhibitors |
| 01/07/1992 | US5079361 Crosslinking Of Polypeptides Or Proteins With A Reagent Containing A Vinyl Group Conjugated With An Aromatic Nitrogen Heterocycle |
| 01/07/1992 | US5079353 Sialic acid glycosides, antigens, immunoadsorbents, and methods for their preparation |
| 01/07/1992 | US5079345 Proteins having growth hormone anabolic properties with reduced effect on carbohydrate metabolism |
| 01/07/1992 | US5079343 AIDS diagnosis |
| 01/07/1992 | US5079342 Diagnosis of AIDS |
| 01/07/1992 | US5079337 Transfusions of synthetic blood; nondiffusing from vascular systems; reversible oxygen carriers |
| 01/07/1992 | US5079336 α-1-antichymotrypsin, analogues and methods of production |
| 01/07/1992 | US5079231 Immunostimulating peptides, a process for their preparation and pharmaceutical compositions containing them |
| 01/07/1992 | US5079230 Stable bioactive somatotropins |
| 01/07/1992 | US5079229 Modified eglin proteins |
| 01/07/1992 | US5079228 Peptide inhibitors of neutrophil activating factor induced chemotaxis |
| 01/07/1992 | US5079165 Vaccines to prevent cholera and typhoid fever |
| 01/07/1992 | US5079163 Recombinant ricin toxin fragments |
| 01/07/1992 | US5079149 Gel filtration chromatography of membrane from halobacterium cells |
| 01/07/1992 | US5079147 Using DNA sequences to detect chromosome abnormalities |
| 01/07/1992 | US5078996 Genetic engineering, anticancer agents |
| 01/07/1992 | US5078985 Radiolabeling antibodies and other proteins with technetium or rhenium by regulated reduction |
| 01/07/1992 | CA2086761A1 Production of outer membrane (om) proteins in gram-positive bacteria and recovery of protective epitopes |
| 01/07/1992 | CA2086414A1 Retroviral protease inhibitors |
| 01/07/1992 | CA2086411A1 Cdna encoding the rat d1 dopamine receptor linked to adenylyl cyclase activation and expression product |
| 01/07/1992 | CA2046025A1 Vaccine against lyme disease and a challenge model for evaluating vaccine efficiency |
| 01/07/1992 | CA2045951A1 Recombinant dna expression vectors and dna compounds that encode deacetylcephalosporin c synthase activity |
| 01/07/1992 | CA1293941C Method for preparing antihemophilic factor (ahf) by cold precipitation and for improving solubility of recovered ahf product |
| 01/06/1992 | CA2046112A1 Amino acid derivatives |
| 01/05/1992 | CA2039986A1 Process for producing .alpha.-amylase inhibitor derived from wheat seed |
| 01/04/1992 | WO1992000767A1 Composition for stabilizing blood plasma during pasteurization |
| 01/04/1992 | CA2065284A1 Composition for stabilizing blood plasma during pasteurization |
| 01/03/1992 | WO1992000372A1 Recombinant pigeon pox virus vaccine |
| 01/03/1992 | WO1992000319A1 Human meg-csf protein and methods |
| 01/03/1992 | CA2086248A1 Human meg-csf protein and methods |
| 01/03/1992 | CA2084064A1 Recombinant pigeon pox virus vaccine |
| 01/02/1992 | EP0463998A2 Immunological detection of triasulfuron |
| 01/02/1992 | EP0463859A2 Immobilization of biomolecules by enhanced electrophoretic precipitation |
| 01/02/1992 | EP0463848A2 Non-A, non-B hepatitis virus particles |
| 01/02/1992 | EP0463571A2 Recombinant human osteocalcin |
| 01/02/1992 | EP0463450A1 Vasoactive intestinal polypeptide analogues and use thereof |